• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

色满酮衍生物是否能成为 PTR1 的更好抑制剂?——在布鲁氏锥虫和利什曼原虫中其抑制效力存在差异的原因。

Could chroman-4-one derivative be a better inhibitor of PTR1? - Reason for the identified disparity in its inhibitory potency in Trypanosoma brucei and Leishmania major.

机构信息

Molecular Bio-Computation and Drug Design Laboratory, School of Health Sciences, University of KwaZulu-Natal, Westville Campus, Durban, 4001, South Africa.

Department of Veterinary Parasitology and Entomology, Faculty of Veterinary Medicine, University of Ibadan, Nigeria.

出版信息

Comput Biol Chem. 2021 Feb;90:107412. doi: 10.1016/j.compbiolchem.2020.107412. Epub 2020 Nov 7.

DOI:10.1016/j.compbiolchem.2020.107412
PMID:33199197
Abstract

Most notable Kinetoplastids are of the genus Trypanosoma and Leishmania, affecting several millions of humans in Africa and Latin America. Current therapeutic options are limited by several drawbacks, hence the need to develop more efficacious inhibitors. An investigation to decipher the mechanism behind greater inhibitory potency of a chroman-4-one derivative (compound 1) in Trypanosoma brucei pteridine reductase 1 (TbPTR1) and Leishmania major pteridine reductase 1 (LmPTR1) was performed. Estimation of ΔG revealed that compound 1 had a greater binding affinity in TbPTR1 with a ΔG value of -49.0507 Kcal/mol than -29.2292 Kcal/mol in LmPTR1. The ΔGbind in TbPTR1 were predominantly contributed by "strong" electrostatic energy compared to the "weak" van der Waals in LmPTR1. In addition to this, the NADPH cofactor contributed significantly to the total energy of TbPTR1. A characteristic weak aromatic π interaction common in PTR1 was more prominent in TbPTR1 than LmPTR1. The consistent occurrence of high-affinity conventional hydrogen bond interactions as well as a steady interaction of crucial active site residues like Arg14/Arg17, Ser95/Ser111, Phe97/Phe113 in TbPTR1/LmPTR1 with chroman-4-one moiety equally revealed the important role the moiety played in the activity of compound 1. Overall, the structural and conformational analysis of the active site residues in TbPTR1 revealed them to be more rigid than LmPTR1. This could be the mechanism of interaction TbPTR1 employs in exerting a greater potency than LmPTR1. These findings will further give insight that will be assistive in modifying compound 1 for better potency and the design of novel inhibitors of PTR1.

摘要

最著名的锥虫是锥体虫属和利什曼原虫属,影响着非洲和拉丁美洲的数百万人。目前的治疗选择受到多种缺陷的限制,因此需要开发更有效的抑制剂。为了解释色满-4-酮衍生物(化合物 1)在布氏锥虫喋啶还原酶 1(TbPTR1)和利什曼原虫喋啶还原酶 1(LmPTR1)中抑制活性更强的机制,进行了一项研究。ΔG 的估计表明,化合物 1 在 TbPTR1 中的结合亲和力更大,ΔG 值为-49.0507 Kcal/mol,而在 LmPTR1 中为-29.2292 Kcal/mol。与 LmPTR1 中的“弱”范德华力相比,TbPTR1 中的ΔGbind 主要由“强”静电能贡献。此外,NADPH 辅因子对 TbPTR1 的总能量有显著贡献。在 PTR1 中常见的特征性弱芳香π相互作用在 TbPTR1 中比在 LmPTR1 中更为突出。高亲和力常规氢键相互作用的一致发生以及关键活性位点残基如 Arg14/Arg17、Ser95/Ser111、Phe97/Phe113 与色满-4-酮部分的稳定相互作用同样表明该部分在化合物 1 的活性中起着重要作用。总的来说,TbPTR1 中活性位点残基的结构和构象分析表明,它们比 LmPTR1 更具刚性。这可能是 TbPTR1 发挥比 LmPTR1 更强活性的相互作用机制。这些发现将进一步提供深入了解,有助于修饰化合物 1 以提高其效力,并设计 PTR1 的新型抑制剂。

相似文献

1
Could chroman-4-one derivative be a better inhibitor of PTR1? - Reason for the identified disparity in its inhibitory potency in Trypanosoma brucei and Leishmania major.色满酮衍生物是否能成为 PTR1 的更好抑制剂?——在布鲁氏锥虫和利什曼原虫中其抑制效力存在差异的原因。
Comput Biol Chem. 2021 Feb;90:107412. doi: 10.1016/j.compbiolchem.2020.107412. Epub 2020 Nov 7.
2
Chroman-4-One Derivatives Targeting Pteridine Reductase 1 and Showing Anti-Parasitic Activity.靶向蝶啶还原酶1并具有抗寄生虫活性的色满-4-酮衍生物。
Molecules. 2017 Mar 8;22(3):426. doi: 10.3390/molecules22030426.
3
Enhancement of Benzothiazoles as Pteridine Reductase-1 Inhibitors for the Treatment of Trypanosomatidic Infections.苯并噻唑类作为蝶呤还原酶-1 抑制剂增强剂用于治疗锥虫感染。
J Med Chem. 2019 Apr 25;62(8):3989-4012. doi: 10.1021/acs.jmedchem.8b02021. Epub 2019 Apr 9.
4
Identification of Novel Potential Inhibitors of Pteridine Reductase 1 in via Computational Structure-Based Approaches and in Vitro Inhibition Assays.通过计算结构基础方法和体外抑制试验鉴定 中的新型蝶呤还原酶 1 潜在抑制剂。
Molecules. 2019 Jan 1;24(1):142. doi: 10.3390/molecules24010142.
5
High-resolution crystal structure of Trypanosoma brucei pteridine reductase 1 in complex with an innovative tricyclic-based inhibitor.布氏锥虫喋呤还原酶 1 与新型三环为基础的抑制剂复合物的高分辨率晶体结构
Acta Crystallogr D Struct Biol. 2020 Jun 1;76(Pt 6):558-564. doi: 10.1107/S2059798320004891. Epub 2020 May 29.
6
Structure and reactivity of Trypanosoma brucei pteridine reductase: inhibition by the archetypal antifolate methotrexate.布氏锥虫蝶啶还原酶的结构与反应活性:原型抗叶酸药物甲氨蝶呤的抑制作用
Mol Microbiol. 2006 Sep;61(6):1457-68. doi: 10.1111/j.1365-2958.2006.05332.x.
7
Identification of a 2,4-diaminopyrimidine scaffold targeting Trypanosoma brucei pteridine reductase 1 from the LIBRA compound library screening campaign.从 LIBRA 化合物库筛选活动中鉴定出一种针对布氏锥虫喋呤还原酶 1 的 2,4-二氨基嘧啶骨架。
Eur J Med Chem. 2020 Mar 1;189:112047. doi: 10.1016/j.ejmech.2020.112047. Epub 2020 Jan 10.
8
In Silico Identification and In Vitro Evaluation of Natural Inhibitors of Leishmania major Pteridine Reductase I.基于计算机的鉴定和体外评估利什曼原虫喋呤还原酶 I 的天然抑制剂。
Molecules. 2017 Dec 6;22(12):2166. doi: 10.3390/molecules22122166.
9
Dissecting the metabolic roles of pteridine reductase 1 in Trypanosoma brucei and Leishmania major.解析喋呤还原酶 1 在布氏锥虫和利什曼原虫中的代谢作用。
J Biol Chem. 2011 Mar 25;286(12):10429-38. doi: 10.1074/jbc.M110.209593. Epub 2011 Jan 14.
10
In Silico and In Vitro Search for Dual Inhibitors of the and Pteridine Reductase 1 and Dihydrofolate Reductase.计算机模拟和体外实验寻找蝶啶还原酶1和二氢叶酸还原酶的双重抑制剂
Molecules. 2023 Nov 10;28(22):7526. doi: 10.3390/molecules28227526.

引用本文的文献

1
Comparison and Analysis on the Existing Single-Herbal Strategies against Viral Myocarditis.比较和分析现有针对病毒性心肌炎的单味中药策略。
Genet Res (Camb). 2021 Aug 7;2021:9952620. doi: 10.1155/2021/9952620. eCollection 2021.
2
Synthesis and Evaluation of Novel 2,2-Dimethylthiochromanones as Anti-Leishmanial Agents.新型 2,2-二甲基硫代色满酮的合成与评价作为抗利什曼原虫药物。
Molecules. 2021 Apr 12;26(8):2209. doi: 10.3390/molecules26082209.